Skip to content
Review Open access

Plasma Citrulline as a Biomarker in Critical Illness: A Structured Narrative Review

Sep 2026 · Diagnostics · Vol 16, pp. 2831 · 0 citations · 52 references
Medicine

TL;DR

Current evidence does not support its use as a standalone diagnostic or prognostic biomarker in critical illness, and further prospective studies using standardized measurement protocols and serial assessment are needed to determine its potential role alongside clinical evaluation and complementary biomarkers.

Abstract

Introduction: Gastrointestinal dysfunction is common in critically ill patients and is associated with increased morbidity and mortality. Plasma citrulline, a non-proteinogenic amino acid synthesized by enterocytes, has been proposed as a biomarker of intestinal function and enterocyte mass. However, the available evidence regarding its clinical significance in critically ill patients remains heterogeneous. This structured narrative review aimed to evaluate the current evidence on plasma citrulline in critical illness, focusing on its association with gastrointestinal dysfunction, disease severity, and clinical outcomes. Methods: A structured narrative review based on a structured literature search was conducted using PubMed and Scopus. Reference lists of included studies and relevant reviews were also screened. Studies evaluating circulating citrulline in adult critically ill patients and reporting gastrointestinal dysfunction, intestinal injury, disease severity, or other relevant clinical outcomes were included. Study selection was performed by two reviewers, and data were analyzed descriptively. Results: Eleven studies met the inclusion criteria, the majority being prospective observational studies. The timing of citrulline measurement, patient populations, analytical methods, and evaluated outcomes varied considerably across studies. Lower circulating citrulline concentrations were frequently associated with gastrointestinal dysfunction or markers of intestinal impairment; however, associations with disease severity, mortality, and other clinical outcomes were inconsistent. Several factors, including renal function, systemic inflammation, and methodological variability, may influence the interpretation of circulating citrulline concentrations. Conclusions: Plasma citrulline may provide complementary information regarding enterocyte function and gastrointestinal dysfunction in critically ill patients. However, current evidence does not support its use as a standalone diagnostic or prognostic biomarker. Further prospective studies using standardized measurement protocols and serial assessment are needed to determine its potential role alongside clinical evaluation and complementary biomarkers.

Read PDF

Similar papers

Review Open access Sep 2026

THE CLINICAL UTILITY OF PRESEPSIN (sCD14-ST) AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN SEPSIS: A COMPREHENSIVE REVIEW

Purpose: This review provides a comprehensive synthesis of current evidence regarding the diagnostic and prognostic utility of presepsin (soluble CD14 subtype, sCD14-ST) in sepsis by critically evaluating its role in early diagnosis, disease severity assessment, septic shock identification, and prediction of clinical o...

Wojciech Gawęda, Wiktoria Łobodzińska, Maciej Ficek et al. · 0 citations
Review Open access Sep 2026

Diagnostic Value of Serum Amyloid A in Neonatal Sepsis: A Literature Review

Neonatal sepsis remains a major cause of morbidity and mortality worldwide, while early diagnosis is challenging due to nonspecific clinical manifestations and the limited accuracy of currently available biomarkers. Serum amyloid A (SAA), a rapidly responding acute-phase protein, has emerged as a potential adjunctive b...

B. A. Stoia, Ioana Arbanaș, V. Spoulou et al. · 0 citations
Review Open access Sep 2026

Neutrophil-to-Lymphocyte Ratio in Predicting Severity in Acute Pancreatitis: A Systematic Review and Exploratory Meta-Analysis

Background: Early identification of patients at risk of severe acute pancreatitis (AP) remains clinically important. The neutrophil-to-lymphocyte ratio (NLR) is inexpensive, rapidly available, and has been investigated as a prognostic biomarker, but reported thresholds, measurement times, and target outcomes vary subst...

Husain Ali Abdulaziz Hasan Husain, Hasan Jasim Isa Abdulla Darwish, Ebrahim Isa Ebrahim Hasan Ebrahim et al. · 0 citations
Open access Oct 2026

Critical Episodes of Inflammation, Catabolism, and Immunosuppression Define Mortality Risk in Chronic Critical Illness

Background/Objectives: A globally recognized definition of chronic critical illness (CCI) is lacking. Temporal criteria produce variable estimates, while pathophysiological models emphasize inflammation, catabolism, and immunosuppression (ICS). The relationship between ICS dynamics and mortality remains unclear. Method...

V. Likhvantsev, L. Berikashvili, P. Polyakov et al. · 0 citations
Review Open access Nov 2026

Systemic corticosteroids in critical illness: an evidence-based framework for clinical decision-making

Systemic corticosteroids are pivotal in managing inflammation-driven critical illnesses, yet bedside translation remains inconsistent. This systematic review establishes an evidence-based framework for clinical decision-making by horizontally synthesizing contemporary evidence across severe community-acquired pneumonia...

Yu-Wen Chang, Chun-Fu Chung, Suey-Haur Lee et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.